loader2
Partner With Us NRI
Maruti Suzuki India Ltd>
  • CMP : 12,711.0 Chg : 305.95 (2.47%)
  • Target : 11,200.0 (28.74%)
  • Target Period : 12-18 Month

30 Jan 2023

Higher ASP & other income drive PAT outperformance

About The Stock

Maruti Suzuki (MSIL) is the market leader in the domestic passenger vehicle (PV) space with market share pegged at ~43.4% and popular models being Alto, WagonR, Swift, Brezza, Baleno, Ertiga, etc., among others.

  • Market leader in each sub-segment - cars (63.6%), UV (19.5%), vans (95.7%)
  • Strong b/s; ~₹ 42,000 crore cash and investment on books as of FY22
Q3FY23

The company posted steady performance in Q3FY23.

  • Total operating income came in at ₹ 29,044 crores down 3% QoQ. With 10% QoQ drop in volumes, ASP’s surprised positively at ₹6 lakh/unit, up 8% QoQ
  • EBITDA margins in Q3FY23 stood at 9.8%, up 50 bps QoQ
  • Consequent PAT stood at ₹ 2,833 crore up 14% QoQ. PAT performance was driven by higher other income which for the quarter stood at ₹861 crore.
What should Investors do?

MSIL’s stock price has de-grown at ~1.3% CAGR from
~₹ 9,280 levels in Jan 2018, underperforming the broader Nifty Auto index.

  • We retain our BUY rating tracking reignited focus towards SUV’s, market share gains ambition, clear timeframe for EV launch & robust order-book.
Target Price and Valuation

Introducing FY25E, we now value MSIL at unchanged target price of ₹ 11,200 i.e., 28x P/E on FY24E-25E average EPS of ₹400/share.

Key Triggers for future price performance
  • Robust demand in SUV space aided by new launches, bookings for higher end models & greater UV share to lead healthy uptick in volumes and ASPs’, we have built 23%/13.3% sales/volume CAGR for FY22-25E.
  • Leadership position in the CNG space with CNG penetration at >20% of sales volume amid strong new offerings like Grand Vitara, XL6, Baleno, etc
  • Technology work being done in the alternate fuel vehicle domain; flex fuel (ethanol powered) vehicle & BEV’s showcased in Auto Expo 2023.
  • Robust order backlog of >3.6 lakh units amid improved supply side situation
  • Aggressive capex spends to augment capacities both brownfield (Manesar ~1 lakh units) and greenfield (new plant in Haryana, first phase capacity pegged at ~2.5 lakh units) to ensure sufficient capacity to meet demand.
Alternate Stock Ideas

Apart from MSIL, in our OEM coverage we like M&M.

  • Focused on prudent capital allocation, UV differentiation & EV proactiveness

 

  • BUY with target price of ₹ 1,590

Key Financial Summary

Key Financials FY20 FY21 FY22 5 year CAGR (FY17-22) FY23E FY24E FY25E 3 year CAGR (FY22-25E)
Total Operating Income 75,610.6 70,332.5 88,295.6 5.4 118,452.8 145,995.9 164,288.8 23.0
EBITDA 7,302.6 5,345.3 5,701.2 -11.2 10,800.5 14,662.7 17,244.9 44.6
EBITDA Margins (%) 9.7 7.6 6.5 - 9.1 10.0 10.5 -
Net Profit 5,650.6 4,229.7 3,766.3 -12.5 7,912.1 11,148.3 13,033.3 51.3
EPS (₹) 187.1 140.0 124.7 - 261.9 369.0 431.5 -
P/E 46.5 62.1 69.8 - 33.2 23.6 20.2 -
RoNW (%) 11.7 8.2 7.0 - 13.3 16.7 17.2 -
RoIC (%) 26.8 24.2 24.5 - 65.6 106.5 76.7 -
Source: Company, ICICI Direct Research

Key takeaways of the recent quarter & Concall highlights

Q3FY23 Results:

  • Total operating income for the quarter stood at | 29,044 down 3% QoQ. Q3FY23 volumes were at 4.7 lakh units, down 10% QoQ. Of this, domestic volumes de-grew by 11% QoQ to 4 lakh units, while exports volumes were down 2% QoQ at 0.62 lakh units. 
  • Average Selling Price (ASP) came in at | 5.98 lakh/unit, up 8.3% QoQ.
  • EBITDA in Q3FY23 stood at ₹ 2,833 crore with corresponding EBITDA margins placed at 9.8%, up ~50 bps QoQ. Gross margin expansion came in lower than anticipated at 44 bps QOQ while savings were realised on the other expenses front which was down 42 bps QoQ, leading to a marginal miss on the overall operating margin profile.
  • Consequent PAT in Q3FY23 came in at | 2,351 crore, up 14% QoQ. PAT performance was driven by higher other income (up 40% QoQ; ₹861 crore)

Q3FY23 Earnings Conference Call highlights    

 

  • Company remained optimistic about regaining 50% market share amidst new launches like Jimny & Fronx showcased in Auto Expo 2023. Further company also unveiled evolving technologies like BEV’s & Flex Fuel Engine to be launched by 2025 with ~|100 billion investment planned in EV domain in the state of Gujarat by parent i.e., Suzuki Motors.
  • Company informed about crossing 25 million productions (cumulative) with 3,500+ sales network. During the quarter, it started export of grand Vitara in Latin America, South America, Asian and near by countries.
  • Management informed ~46,000 units’ production lost due to chip shortage in Q3FY23 vs ~35,000 lost in Q2FY23. Company expects Q4FY23 to be better in terms of chip supply. The supply situation is however uncertain.
  • Rise in realization was largely due to bookings for higher end models for recent launches & greater share of SUVs in overall portfolio. Company informed about lean stock with network at end of quarter (at ~5 days).
  • Company continues to witness strong order book of ~3.63 lakh units as on Q3FY23 vs ~4.1 lakh units in Q2FY23. With respect to launch of recent products they received ~1.2 lakh bookings.
  • Management informed about large part of commodity benefits being accrued till date incl. Q3FY23 with minimal benefits to accrue in Q4FY23.
  • Management informed about higher promotional spends impacting margins in Q3FY23 which was mitigated via commodity benefits, currency benefits & cost reduction efforts. Royalty rate for Q3FY23 stood at ~3.9%.
  • Avg. discount per car stood at ~₹ 18,291 during Q3FY23 vs. ~₹13,840 in Q2FY23 & ~|15,200 in Q3FY22.
  • Jimmy and Fronx are slated for commercial launch/delivery in Q1FY24.
  • Company informed about demand remaining healthy with rural demand being strong and accounting for 44-45% of total sales.

  • Company has ~ 100-billion-yen exposure.

  • Management informed about cost impact of ~₹20,000 due to mandatory safety regulation (i.e., 6 airbags, 3-point seatbelts, seatbelt reminder etc. which includes sensors & controllers)

  • Retails during the quarter stood at 4.8 lakh

  • Company is comfortably placed meeting the CAFÉ norms and in fact has the lowest average fleet emission across the industry.

  • On BS-VI stage 2 (OBD-2, RDE) it is also well placed with minimal cost implications

  • Starting April 2023 all models at the company will be E-20 compliant (ethanol blending) with first flex fuel vehicle slated to be launched in 2025 (E-85).

  • Management opined that vehicles running on E-85 blended fuel will have ~79% less emissions vs. non blended run vehicles however the fuel needs to be cheaper by ~35% so that running costs/km remains similar for a vehicle owner

  • Higher CNG prices is denting demand of vehicles on the commercial side with company engaging with authorities for some remedy on this front

  • MSIL endeavor will be to grow ahead of industry going forward

Disclaimer

ANALYST CERTIFICATION

I/We, Shashank Kanodia, CFA, MBA (Capital Markets), and Raghvendra Goyal, CA, Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. It is also confirmed that above mentioned Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months and do not serve as an officer, director or employee of the companies mentioned in the report.

Terms & conditions and other disclosures:

ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial products.

ICICI Securities is Sebi registered stock broker, merchant banker, investment adviser, portfolio manager and Research Analyst. ICICI Securities is registered with Insurance Regulatory Development Authority of India Limited (IRDAI) as a composite corporate agent and with PFRDA as a Point of Presence. ICICI Securities Limited Research Analyst SEBI Registration Number – INH000000990. ICICI Securities Limited SEBI Registration is INZ000183631 for stock broker. ICICI Securities is a subsidiary of ICICI Bank which is India’s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. (“associates”), the details in respect of which are available on www.icicibank.com.

 

ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. ICICI Securities and its analysts, persons reporting to analysts and their relatives are generally prohibited from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover.

 

Recommendation in reports based on technical and derivative analysis centre on studying charts of a stocks price movement, outstanding positions, trading volume etc as opposed to focusing on a companys fundamentals and, as such, may not match with the recommendation in fundamental reports. Investors may visit icicidirect.com to view the Fundamental and Technical Research Reports.

 

Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein.

 

ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Retail Research. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, and target price of the Institutional Research.

 

The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances.

 

This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice.

 

ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months.

 

ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction.

 

ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the companies mentioned in the report in the past twelve months.

 

 

ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its associates or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of interest at the time of publication of this report.

 

Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.

 

ICICI Securities or its subsidiaries collectively or Research Analysts or their relatives do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report.

 

Since associates of ICICI Securities and ICICI Securities as a entity are engaged in various financial service businesses, they might have financial interests or actual/ beneficial ownership of one percent or more or other material conflict of interest various companies including the subject company/companies mentioned in this report.

 

ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.

 

Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report.

 

We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities.

 

This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.

 

 

Read More